Microbiotix, Inc.
Microbiotix, Inc. is a clinical stage biopharmaceutical company dedicated to the discovery and development of proprietary small molecule drugs targeting serious infectious diseases, including multi-drug resistant pathogens. The company is recognized for its innovation and has consistently been a top recipient of NIH awards among Massachusetts biotech/pharma companies.
Microbiotix, Inc.
One Innovation Drive, Worcester, MA 01605
Patents
Metabolically stable N-acylaminooxadiazoles useful as antibacterial agents
2022-11-22 • US-11505533-B2
View DetailsWhat We Do
A potent and novel nucleoside analog dual DNA polymerase/kinase inhibitor for the treatment of human cytomegalovirus (CMV). MBX-400 has successfully completed Phase 1 clinical testing.
Key People
President & CEO
Chief Business Officer
News & Updates
Microbiotix has consistently been the top recipient of NIH awards amongst Massachusetts biotech/pharma companies.